Uploaded February 2026 | Updated September 2026, 3 days ago
Diabetes and dementia are increasingly interconnected challenges in clinical care.
In this EASD TV episode, Prof. Gill Livingston (University College London) and Prof. Thomas van Sloten (UMC Utrecht) examine the growing evidence linking diabetes, particularly type 2 diabetes, with an increased risk of dementia.
As cardiovascular outcomes improve and people with diabetes live longer, cognitive decline is becoming more prevalent in clinical practice. The discussion explores:
• Why dementia risk is higher in people with diabetes
• The impact of cognitive impairment on diabetes self-management
• Prevention through lifestyle, vascular risk control and adherence
• The emerging evidence around GLP-1 receptor agonists and SGLT2 inhibitors
• Why future clinical trials must include cognitive outcomes
This episode highlights a major shift: brain health is now central to long-term diabetes care.
Watch, share and subscribe for more expert discussions from EASD TV.
Diabetes and dementia are increasingly interconnected challenges in clinical care.
In this EASD TV episode, Prof. Gill Livingston (University College London) and Prof. Thomas van Sloten (UMC Utrecht) examine the growing evidence linking diabetes, particularly type 2 diabetes, with an increased risk of dementia.
As cardiovascular outcomes improve and people with diabetes live longer, cognitive decline is becoming more prevalent in clinical practice. The discussion explores:
• Why dementia risk is higher in people with diabetes
• The impact of cognitive impairment on diabetes self-management
• Prevention through lifestyle, vascular risk control and adherence
• The emerging evidence around GLP-1 receptor agonists and SGLT2 inhibitors
• Why future clinical trials must include cognitive outcomes
This episode highlights a major shift: brain health is now central to long-term diabetes care.
Watch, share and subscribe for more expert discussions from EASD TV.
